Yi Du1,
Fen Zhao1,
Ni Zhang2,
Guoxiao Yu3,
Lei Shi2,
Juan Li2
For correspondence:- Juan Li Email: lijuan5220@163.com Tel:+8613588113618
Accepted: 12 May 2022 Published: 30 June 2022
Citation: Du Y, Zhao F, Zhang N, Yu G, Shi L, Li J. BCL9 enhances the development of cervical carcinoma by deactivating CPEB3/EGFR axis. Trop J Pharm Res 2022; 21(6):1147-1152 doi: 10.4314/tjpr.v21i6.2
© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates